PreClinical and clinical studies to evaluate safety and Efficacy of a Topical Unani formulation in Dermatophytosis.

Preclinical and Clinical studies to evaluate the safety and efficacy of Unani Topical Formulation for Dermatophytosis. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/083050

Enrollment

Registered

2025-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: -

Interventions

Intervention1: Unani Formulated Ointment (UFO): Contains: Sulphur(Gandhak) Borax(Suhaga) Ammonium Chloride(Naushadar) Limestone(Ahak ) Quercus incana (Mazu) Allium sativum(Lehsun) Roghan Kunjud( Sesa

Eligibility

Inclusion criteria

Inclusion criteria: fungal hyphae in a 10% potassium hydroxide (KOH) Patients aged 14year old to 65 years old.

Exclusion criteria

Exclusion criteria: Immunocompromised Pregnant ladies Lactating women Patients with secondarily infected or eczematized lesions Medical comorbidities Uncontrolled Diabetes

Design outcomes

Primary

Measure	Time frame
To evaluate the safety and effficacy of the Unani Formulated Ointment in Dermatophytosis.Timepoint: To evaluate the safety and effficacy of the Unani Formulated Ointment in Dermatophytosis.	—

Secondary

Measure	Time frame
Correlate the efficacy with the MIC.Timepoint: 20/04/25	—

Countries

India

Contacts

Public ContactPROF ZAMIR AHMAD

AJMAL KHAN TIBBIYA COLLEGE

drzamiramrohi@gmail.com8475007594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026